Loading…
← CockpitCompetitor Analysis › ASTERDM.NS Aster DM Quality CareOpen in the cockpit ↗

Aster DM Quality CareASTERDM.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management

Operates hospitals, clinics and pharmacies across India (post its Gulf business demerger), providing multi-specialty healthcare services.

≈ India's smaller HCA HealthcareMomentum neutral 48
Mkt cap
$6.83B
US dollars, full cap
Free float
38%
of shares outstanding
$/day
$8.12M
20-day average traded
Fwd P/E
63.5×
forward earnings
ROIC−WACC
-7.4 pp
WACC 12.7%
Hurdle
+60 pp
Req g minus delivered
Next earnings
83 days
9 Feb 2027
Close · INR₹731.00
1D-0.9%
1W+0.9%
1M+9.6%
3M-10.6%
6M-2.4%
YTD+18.5%
1Y+7.3%
ATR %3.6%
Beta0.35
52w lowhigh18.0% off high

What Aster DM Quality Care does

Operates hospitals, clinics and pharmacies across India (post its Gulf business demerger), providing multi-specialty healthcare services.

In one line: India's smaller HCA Healthcare.

Products and services

  • Multi-specialty hospitals
  • Clinics
  • Pharmacies

Customers

  • Patients in India (South India focus)
  • Health insurers

Where it sits in the supply chain

  • Healthcare
  • Hospitals
  • Multi-specialty healthcare - India

What could go right

  • Rising healthcare spending in India
  • Bed capacity/hospital network expansion

What could go wrong

  • Regulatory/pricing caps on healthcare services
  • High capex intensity of hospital expansion

Moat: narrow (brand, installed base, regulatory licence). An established hospital network and brand trust in South India, though healthcare faces significant local/regional competition.

Headquarters: Kochi, India · Founded: 1987 · Employees: 22,413

Named competitors

Aster DM Quality Care at a glance

Size Aster DM Quality Care (ASTERDM.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $6.83B, the 170th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹731.00 on 18 Nov 2026.

Performance Over six months the shares fell 2.4%, against +6.2% for the median peer and +3.8% for the India market (cap-weighted) — 7th lowest of 19 in its peer set.

Growth Revenue grew 50.5% over the last twelve months (peer median +8.0%); the operating margin is 15.6% (peer median 12.7%).

Valuation It trades at 63.5× forward earnings against a peer median of 32.8× (5th most expensive of 19).

Price implies For today's price to make sense, revenue must grow about 49% a year for seven years (Req g). Recent delivered growth is -12%, so the hurdle is +60 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 7.4 points below its cost of capital (12.7% WACC).

Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026Peer median 106ASTERDM.NS 96
Six months, rebased to 100: Aster DM Quality Care against the median of its 19 peers (local-currency closes).

Aster DM Quality Care financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹65.1B₹46.4B₹41.4B₹37.0B₹29.9B
Revenue growth—+12%+12%+24%—
Gross profit₹20.8B₹10.8B₹9.04B₹7.27B₹5.20B
EBITDA₹13.7B₹9.25B₹7.81B₹5.94B₹4.61B
Net income₹4.71B₹3.88B₹53.8B₹1.29B₹4.25B
Free cash flown/a₹2.01B₹867M-₹8.48B₹9.70B
Capital expendituren/a₹4.78B₹3.57B₹8.06B₹8.48B
Total debt₹59.4B₹22.2B₹20.2B₹13.8B₹57.0B

Quarterly statements and history in the cockpit →

Aster DM Quality Care competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%0%+50%CHEFORTISPACSRHCMAXHEALTHUHSNHMEDANTASGRYKIMSNHC600763THCBKDARDT301267ASTERDM.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Aster DM Quality Care is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%0×200×400×CHEFORTISPACSMANIPALHOSMAXHEALTHNHMEDANTASGRYKIMSBKDARDTEXEASTERDM.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Aster DM Quality Care is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%CHEFORTISPACSRHCMANIPALHOSMAXHEALTHUHSNHSGRYAPOLLOHOSPNHCTHCBKD301267ASTERDM.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Aster DM Quality Care is the large dot.

Aster DM Quality Care competitors and peer comparison

Head to head with its named competitors (ASTERDM.NS vs FORTIS.NS vs APOLLOHOSP.NS vs MAXHEALTH.NS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Aster DM Quality Care ASTERDM.NS$6.83B-2%+50%16%63.5×48.6%
Fortis Healthcare FORTIS.NS$6.40B-17%+18%17%48.5×42.5%
Apollo Hospitals Enterprise APOLLOHOSP.NS$13.6B+10%+19%12%51.0×33.3%
Max Healthcare Institute MAXHEALTH.NS$10.6B-4%+15%21%55.2×45.3%
Narayana Hrudayalaya NH.NS$4.13B0%+71%13%34.2×31.2%
Krishna Institute of Medical Sciences KIMS.NS$3.41B+2%+35%11%81.9×n/a
Global Health MEDANTA.NS$4.13B+16%+26%17%50.4×n/a

How Aster DM Quality Care compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Aster DM Quality Care against its 19 peers (data as of 18 Nov 2026)
MeasureASTERDM.NSPeer medianRank in peer set
1-month return+9.6%+6.7%7th highest of 20
6-month return-2.4%+6.2%7th lowest of 19
Distance from 52-week high-18.0%-13.7%9th lowest of 20
Revenue growth (TTM)+50.5%+8.0%2nd highest of 20
Operating margin15.6%12.7%7th highest of 20
Forward P/E63.5×32.8×5th most expensive of 19
Growth the price implies (Req g, 7 yrs)48.6%12.4%most demanding of 18
Growth delivered (Del g)-11.6%+9.7%lowest of 18
Hurdle (Req g minus delivered)+60.2 pp+3.4 ppmost demanding of 18
ROIC minus cost of capital-7.4 pp+0.5 pp2nd lowest of 20
EV / EBITDA50.3×19.1×most expensive of 17
Net debt / EBITDA2.7×2.2×8th most indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Aster DM Quality Care ASTERDM.NSIndia$6.83B-2%+50%16%63.5×48.6%-11.6%
Chemed CHEUnited States$7.12B+24%+5%14%20.2×3.3%+4.0%
Fortis Healthcare FORTIS.NSIndia$6.40B-17%+18%17%48.5×42.5%+17.9%
PACS PACSUnited States$7.35B+25%+11%8%17.5×7.5%+29.7%
Ramsay Health Care RHC.AXAustralia$8.31B+41%+4%5%31.4×14.0%+8.3%
Manipal Health Enterprises MANIPALHOS.NSIndia$9.69Bn/a+25%19%66.5×32.9%+28.8%
Max Healthcare Institute MAXHEALTH.NSIndia$10.6B-4%+15%21%55.2×45.3%+27.2%
Universal Health Services UHSUnited States$10.7B+13%+8%11%8.3×-1.8%+8.5%
Narayana Hrudayalaya NH.NSIndia$4.13B0%+71%13%34.2×31.2%+25.0%
Global Health MEDANTA.NSIndia$4.13B+16%+26%17%50.4×n/an/a
Surgery Partners SGRYUnited States$3.53B+100%+2%13%77.2×15.6%+12.2%
Apollo Hospitals Enterprise APOLLOHOSP.NSIndia$13.6B+10%+19%12%51.0×33.3%+19.0%
Krishna Institute of Medical Sciences KIMS.NSIndia$3.41B+2%+35%11%81.9×n/an/a
National HealthCare NHCUnited States$3.16B+1%+6%0%n/a6.4%+9.7%
Topchoice Medical 600763.SSChina$2.33B-12%+7%26%24.8×12.4%+6.9%
Tenet Healthcare THCUnited States$21.6B+45%+6%17%13.4×-1.4%+3.9%
Brookdale Senior Living BKDUnited States$2.06B-36%-8%6%482.6×19.3%-1.4%
Ardent Health ARDTUnited States$2.03B+52%+2%5%11.9×-1.7%+8.7%
Extendicare EXE.TOCanada$1.91B-16%+36%9%19.3×10.8%+8.5%
Huaxia Eye Hospital 301267.SZChina$1.78B-18%+2%15%23.5×2.1%+10.4%

Questions

Who are Aster DM Quality Care's main competitors?
Named competitors: Fortis Healthcare (FORTIS.NS), Apollo Hospitals (APOLLOHOSP.NS), Max Healthcare Institute (MAXHEALTH.NS), Narayana Hrudayalaya (NH.NS), Krishna Institute of Medical Sciences (KIMS.NS), Global Health (Medanta) (MEDANTA.NS). The cockpit's measured peer set (industry) also includes Chemed (CHE), Fortis Healthcare (FORTIS.NS), PACS (PACS), Ramsay Health Care (RHC.AX), Manipal Health Enterprises (MANIPALHOS.NS), Max Healthcare Institute (MAXHEALTH.NS).
Is Aster DM Quality Care expensive compared with its peers?
On forward p/e it trades at 63.5× against a peer median of 32.8×, 5th most expensive of 19 in its peer set. For today's price to make sense, revenue must grow about 49% a year for seven years (Req g). Recent delivered growth is -12%, so the hurdle is +60 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Aster DM Quality Care stock performed?
Over six months to 18 Nov 2026 the shares returned -2.4% against +6.2% for the median peer; over one year +7.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.